MSK1 has been involved in various inflammatory diseases such as asthma, psoriasis, atherosclerosis [7,11,12,13,14,15], suggesting that MSK1 could be a potential therapeutic target for such inflammatory disorders. Here, RPS6KA5 is linked to psoriasis.